Our content is fact checked by our senior editorial staff to reflect accuracy and ensure our readers get sound information and advice to make the smartest, healthiest choices.
The vaccines will be available through Moderna, Novavax, and Pfizer some time this fall, the release notes. The vaccine from Novavax will target the previously dominantreports. Currently, KP.2 seems to be yielding two additional variants—KP.3 and LB.1—which are responsible for over half of new infections.
"The virus that causes COVID-19, SARS-CoV-2, is always changing and protection from COVID-19 vaccines declines over time," the release reads."Receiving an updated 2024-2025 COVID-19 vaccine can restore and enhance protection against the virus variants currently responsible for most infections and hospitalizations in the United States."
Last year, those who received the 2023-2024 updated vaccine"saw greater protection against illness and hospitalization" than those who didn't," the CDC states.